JP6843140B2 - 肥満および関連する代謝障害を処置するためのビフィドバクテリウム・ロングム - Google Patents

肥満および関連する代謝障害を処置するためのビフィドバクテリウム・ロングム Download PDF

Info

Publication number
JP6843140B2
JP6843140B2 JP2018530515A JP2018530515A JP6843140B2 JP 6843140 B2 JP6843140 B2 JP 6843140B2 JP 2018530515 A JP2018530515 A JP 2018530515A JP 2018530515 A JP2018530515 A JP 2018530515A JP 6843140 B2 JP6843140 B2 JP 6843140B2
Authority
JP
Japan
Prior art keywords
strain
formulation
formulation according
ncimb
longum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018530515A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018536427A (ja
JP2018536427A5 (enExample
Inventor
カイリー，バリー
マーフィー，アイリーン・フランシス
ヒーリー，セレナ
Original Assignee
プリシジョンバイオティクス・グループ・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プリシジョンバイオティクス・グループ・リミテッド filed Critical プリシジョンバイオティクス・グループ・リミテッド
Publication of JP2018536427A publication Critical patent/JP2018536427A/ja
Publication of JP2018536427A5 publication Critical patent/JP2018536427A5/ja
Application granted granted Critical
Publication of JP6843140B2 publication Critical patent/JP6843140B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2018530515A 2015-12-11 2016-12-09 肥満および関連する代謝障害を処置するためのビフィドバクテリウム・ロングム Active JP6843140B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15199660 2015-12-11
EP15199660.0 2015-12-11
PCT/EP2016/080454 WO2017097987A1 (en) 2015-12-11 2016-12-09 Bifidobacterium longum for treating obesity and associated metabolic disorders

Publications (3)

Publication Number Publication Date
JP2018536427A JP2018536427A (ja) 2018-12-13
JP2018536427A5 JP2018536427A5 (enExample) 2020-01-09
JP6843140B2 true JP6843140B2 (ja) 2021-03-17

Family

ID=55070675

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018530515A Active JP6843140B2 (ja) 2015-12-11 2016-12-09 肥満および関連する代謝障害を処置するためのビフィドバクテリウム・ロングム

Country Status (14)

Country Link
US (1) US10973862B2 (enExample)
EP (1) EP3386523B1 (enExample)
JP (1) JP6843140B2 (enExample)
KR (1) KR102819885B1 (enExample)
CN (1) CN109069552B (enExample)
AU (1) AU2016368527B2 (enExample)
BR (1) BR112018011665A2 (enExample)
CA (1) CA3006176C (enExample)
DK (1) DK3386523T3 (enExample)
ES (1) ES2760076T3 (enExample)
MX (1) MX378890B (enExample)
PL (1) PL3386523T3 (enExample)
RU (1) RU2740096C2 (enExample)
WO (1) WO2017097987A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016070151A1 (en) 2014-10-31 2016-05-06 Whole Biome. Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
CN110392734A (zh) 2017-02-28 2019-10-29 营养健康有限公司 可以有益地调节针对呼吸道病毒感染的免疫应答的长双歧杆菌
EP3673044A1 (en) 2017-08-25 2020-07-01 University College Cork-National University of Ireland, Cork Bifidobacterium longum for treating obesity and weight management
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
CN117701424A (zh) * 2018-04-11 2024-03-15 韩国生命工学研究院 具有肥胖预防或治疗效果的新的鼠李糖乳杆菌菌株及其用途
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
KR102224072B1 (ko) * 2019-08-19 2021-03-10 주식회사 빙그레 면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도
WO2021180973A1 (en) 2020-03-13 2021-09-16 Precisionbiotics Group Limited Bifidobacterium longum
CN113564069B (zh) * 2021-05-28 2023-09-29 中山大学 一种长双歧杆菌、长双歧杆菌胞外多糖及其提取方法和应用
CN115466689B (zh) * 2022-02-09 2023-06-16 中国科学技术大学 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用
BG67720B1 (bg) * 2022-03-18 2025-04-30 "Ел Би Булгарикум" ЕАД Щам bifidobacterium longum ssp. longum и бифидобактериален препарат с хиполипидемичен ефект, противовъзпалителен имуномодулиращ ефект и с намаляващ инсулиновата резистентност ефект
CN115637237B (zh) * 2022-09-07 2024-09-17 辽宁贝克瑞生物科技有限公司 一株长双歧杆菌及其应用
KR102789455B1 (ko) * 2025-02-05 2025-04-04 주식회사 리스큐어바이오사이언시스 체지방 저감, 혈당 개선 및 근육 기능 강화 활성이 우수한 비피도박테리움 롱검 아종 롱검 lbmb322020 균주 및 이를 포함하는 대사성 질환 예방, 개선 또는 치료용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
US8557233B2 (en) 2007-03-28 2013-10-15 Alimentary Heath Limited Probiotic bifidobacterium strains
JP2010526055A (ja) * 2007-05-04 2010-07-29 アリメンタリー・ヘルス・リミテッド エキソ多糖
ES2566496T3 (es) * 2008-11-11 2016-04-13 Alimentary Health Limited Bifidobacterium longum
EP2308499A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
CA2779418C (en) * 2009-11-11 2018-03-20 Alimentary Health Limited Probiotic bifidobacterium strain
CA3092318A1 (en) * 2012-09-20 2014-03-27 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions

Also Published As

Publication number Publication date
RU2018119287A (ru) 2020-01-13
WO2017097987A1 (en) 2017-06-15
DK3386523T3 (da) 2020-01-06
MX378890B (es) 2025-03-10
US20190111090A1 (en) 2019-04-18
CA3006176A1 (en) 2017-06-15
CA3006176C (en) 2023-10-31
CN109069552B (zh) 2023-01-24
CN109069552A (zh) 2018-12-21
MX2018006905A (es) 2018-08-24
RU2740096C2 (ru) 2021-01-11
AU2016368527B2 (en) 2023-01-12
JP2018536427A (ja) 2018-12-13
PL3386523T3 (pl) 2020-03-31
KR20180083352A (ko) 2018-07-20
AU2016368527A1 (en) 2018-07-12
RU2018119287A3 (enExample) 2020-06-30
EP3386523B1 (en) 2019-10-09
EP3386523A1 (en) 2018-10-17
US10973862B2 (en) 2021-04-13
BR112018011665A2 (pt) 2018-12-04
KR102819885B1 (ko) 2025-06-12
ES2760076T3 (es) 2020-05-13

Similar Documents

Publication Publication Date Title
JP6843140B2 (ja) 肥満および関連する代謝障害を処置するためのビフィドバクテリウム・ロングム
US11490643B2 (en) Lactobacillus casei for treating obesity and associated metabolic disorders
TWI804945B (zh) 一種短雙歧桿菌207-1及其應用
JP2022000040A (ja) 代謝障害を処置するための低温殺菌アッカーマンシアの使用
TWI594758B (zh) 包含雙歧桿菌的組合物、其製備方法及其用途
MX2013006460A (es) Bifidobacterium cect 7765 y su uso en la prevencion y/o tratamiento del sobrepeso, la obesidad y patologias asociadas.
US20240115625A1 (en) Roseburia hominis, eubacterium eligens, and combinations thereof as biotherapeutics
JP2024529268A (ja) ラクトバチルス属の菌株３種を含む組成物、およびその用途
EP4440588A1 (en) Prevention or treatment of hepatic steatosis
CN110839693A (zh) 吉氏副拟杆菌在预防或治疗肥胖或其相关疾病中的应用
US20200237830A1 (en) Gemella sanguinis as a biotherapeutics
HK40000357A (en) Bifidobacterium longum for treating obesity and associated metabolic disorders
HK40000368A (en) Lactobacillus casei for treating obesity and associated metabolic disorders
TW201336989A (zh) 雙歧桿菌ｃｅｃｔ７７６５及彼於預防及／或治療過重、肥胖症及相關病徵之用途
BALCI PROBIOTIC NUTRITIONS, HEALTH AND OBESITY

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180810

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191125

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191125

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201211

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210118

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210216

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210222

R150 Certificate of patent or registration of utility model

Ref document number: 6843140

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250